Second Primary Malignancies in Hepatocellular Cancer - A US Population-based Study

Area of Science:

• Oncology
• Cancer Epidemiology
• Public Health

Background:

• Second primary malignancies are a significant long-term concern for cancer survivors.
• Hepatocellular carcinoma (HCC) survivors are at risk for developing subsequent cancers.
• Understanding these risks is crucial for improving long-term patient care.

Purpose of the Study:

• To evaluate the risk of second primary malignancies in patients diagnosed with hepatocellular carcinoma (HCC).
• To identify specific cancer types and risk factors associated with secondary malignancies after HCC.
• To inform surveillance and management strategies for HCC survivors.

Main Methods:

• Utilized the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) 13 database.
• Included adult patients (≥18 years) diagnosed with HCC between January 1992 and December 2011.
• Calculated the risk of second primary malignancies using the multiple primary standardized incidence ratio (MP-SIR) method, defining second primary malignancy as a metachronous diagnosis at least 6 months after the index HCC.

Main Results:

• A total of 15,296 HCC patients were analyzed, with 446 (2.83%) developing 466 second primary malignancies.
• The overall observed/expected ratio for second primary malignancies was 10.07 (95% CI=0.97-1.17).
• Significantly increased risks were observed for stomach and thyroid cancers in older patients, and for lung and hepatobiliary cancers after a two-year latency period.

Conclusions:

• The risk of developing specific second primary malignancies after HCC is dependent on patient age.
• Latency period plays a significant role in the risk of certain secondary cancers.
• These findings highlight the need for age- and time-dependent surveillance strategies for HCC survivors.